EDP Sciences logo
Submit your paper
Search
Menu
Home All issues Volume 20 / No 3 (juillet 2014) Med Buccale Chir Buccale, 20 3 (2014) 155-160 References
Open Access
Issue
Med Buccale Chir Buccale
Volume 20, Number 3, juillet 2014
Page(s) 155 - 160
Section Article pédagogique / Educational article
DOI https://doi.org/10.1051/mbcb/2014014
Published online 24 September 2014
  1. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006;42:717-727. [CrossRef] [PubMed] [Google Scholar]
  2. Poulton LD, Smyth MJ, Hawke CG, Silveira P, Shepherd D, Naidenko OV, et al. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int Immunol 2001;13:887-896. [CrossRef] [PubMed] [Google Scholar]
  3. Bose A, Chakraborty T, Chakraborty K, Pal S, Baral R. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients. Cancer Immun 2008;8:10. [PubMed] [Google Scholar]
  4. Millrud CR, Mansson Kvarnhammar A, Uddman R, Bjornsson S, Riesbeck K, Cardell LO. The activation pattern of blood leukocytes in head and neck squamous cell carcinoma is correlated to survival. PLoS One 2012;7:e51120. [CrossRef] [PubMed] [Google Scholar]
  5. Kato H, Whiteside TL. Expression of IL-10 and IL-10 receptors on peripheral blood lymphocytes and monocytes in human head and neck squamous cell carcinoma. Tokai J Exp Clin Med 2011;36:144-151. [PubMed] [Google Scholar]
  6. Wulff S, Pries R, Borngen K, Trenkle T, Wollenberg B. Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages. Anticancer Res 2009;29:3053-3057. [PubMed] [Google Scholar]
  7. Accomando WP, Wiencke JK, Houseman EA, Butler RA, Zheng S, Nelson HH, et al. Decreased NK cells in patients with head and neck cancer determined in archival DNA. Clin Cancer Res 2012;18:6147-54. [CrossRef] [PubMed] [Google Scholar]
  8. Böttcher A, Ostwald J, Guder E, Pau HW, Kramp B, Dommerich S. Distribution of circulating natural killer cells and T lymphocytes in head and neck squamous cell carcinoma. Auris Nasus Larynx 2013;40:216-21. [CrossRef] [PubMed] [Google Scholar]
  9. Molling JW, Langius JA, Langendijk JA, Leemans CR, Bontkes HJ, van der Vliet HJ, et al. Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma. J Clin Oncol 2007; 25:862-868. [CrossRef] [PubMed] [Google Scholar]
  10. El Hage F, Abouzahr-Rifai S, Meslin F, Mami-Chouaib F, Chouaib S. [Immune response and cancer]. Bull Cancer 2008;95:57-67. [PubMed] [Google Scholar]
  11. Swann JB, Smyth MJ. Immune surveillance of tumors. J Clin Invest 2007;117:1137- 46. [CrossRef] [PubMed] [Google Scholar]
  12. Lechner M, Frampton GM, Fenton T, Feber A, Palmer G, Jay A, et al. Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV– tumors. Genome Med 2013;5:49. [CrossRef] [PubMed] [Google Scholar]
  13. Cesson V, Rivals JP, Escher A, Piotet E, Thielemans K, Posevitz V, et al. MAGE-A3 and MAGE-A4 specific CD4(+) T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes. Cancer Immunol Immunother 2011;60:23-35. [CrossRef] [PubMed] [Google Scholar]
  14. Cuffel C, Rivals JP, Zaugg Y, Salvi S, Seelentag W, Speiser DE, et al. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma. Int J Cancer 2011;128:2625-2634. [CrossRef] [PubMed] [Google Scholar]
  15. Badoual C, Hans S, Merillon N, Van Ryswick C,Ravel P, Benhamouda N, et al. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. Cancer Res 2013;73:128-138. [CrossRef] [PubMed] [Google Scholar]
  16. Rajjoub S, Basha SR, Einhorn E, Cohen MC, Marvel DM, Sewell DA. Prognostic significance of tumor-infiltrating lymphocytes in oropharyngeal cancer. Ear Nose Throat J 2007;86:506-511. [PubMed] [Google Scholar]
  17. Nasman A, Romanitan M, Nordfors C, Grun N, Johansson H, Hammarstedt L, et al. Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS One 2012;7:e38711. [CrossRef] [PubMed] [Google Scholar]
  18. Wansom D, Light E, Thomas D, Worden F, Prince M, Urba S, et al. Infiltrating lymphocytes and human papillomavirus-16-associated oropharyngeal cancer. Laryngoscope 2012;122:121-127. [CrossRef] [PubMed] [Google Scholar]
  19. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006;6:295-307. [CrossRef] [PubMed] [Google Scholar]
  20. Allen CT, Judd NP, Bui JD, Uppaluri R. The clinical implications of antitumor immunity in head and neck cancer. Laryngoscope 2012;122:144-57. [CrossRef] [PubMed] [Google Scholar]
  21. Couch ME, Ferris RL, Brennan JA, Koch WM, Jaffee EM, Leibowitz MS, et al. Alteration of cellular and humoral immunity by mutant p53 protein and processed mutant peptide in head and neck cancer. Clin Cancer Res 2007;13:7199-7206. [CrossRef] [PubMed] [Google Scholar]
  22. Ogino T, Shigyo H, Ishii H, Katayama A, Miyokawa N, Harabuchi Y, et al. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. Cancer Res 2006;66:9281-9289. [CrossRef] [PubMed] [Google Scholar]
  23. Badoual C, Combe P, Gey A, Granier C, Roussel H, De Guillebon E, et al. [PD-1 and PDL-1 expression in cancer: significance and prognostic value]. Med Sci (Paris) 2013;29:570-72. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  24. Laimer K, Troester B, Kloss F, Schafer G, Obrist P, Perathoner A, et al. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas. Oral Oncol 2011;47:352-357. [CrossRef] [PubMed] [Google Scholar]
  25. Sparano A, Lathers DM, Achille N, Petruzzelli GJ, Young MR. Modulation of Th1 and Th2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2004;131:573-576. [CrossRef] [PubMed] [Google Scholar]
  26. Almand B, Clark JI, Nikitina E, van Beynen J, English NR, Knight SC, et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 2001;166:678-689. [CrossRef] [PubMed] [Google Scholar]
  27. Gutschalk CM, Herold-Mende CC, Fusenig NE, Mueller MM. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer Res 2006;66:8026-8036. [CrossRef] [PubMed] [Google Scholar]
  28. Carreras J, Lopez-Guillermo A, Fox BC, Colomo L, Martinez A, Roncador G, et al. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 2006;108:2957-2964. [CrossRef] [PubMed] [Google Scholar]
  29. Tougeron D, Fauquembergue E, Latouche JB. [Immune response and colorectal cancer]. Bull Cancer 2013;100:283-294. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.